Partnering for what's next: UMC Groningen

By Philips ∙ May 12 2025 ∙ Duration 4:13

Video

Hospital operations

Patient monitoring

When it was time for University Medical Center Groningen in the Netherlands to consider updating their aging patient monitoring system, they knew it had to be done the right way. UMCG is a teaching hospital with 1,400 beds, providing highly complex medical care supported by 14,000 professionals who count on reliable and secure patient monitoring. Rather than making incremental updates over time, they chose to replace and standardize the entire monitoring system, and sought a business partner who could ease that transition.

Patient Monitoring Informatics Services Agreement

  • UMC Groningen in The Netherlands needed to update an aging patient monitoring system
  • They chose to partner with Philips to help replace and standardize the entire monitoring system, easing the transition
  • A customized patient monitoring system helped clinicians to focus more on patient care, allowing more time at the bedside

Evolving the patient monitoring landscape to prepare for what’s next

Ultimately, UMCG chose to partner with Philips to implement a secure, state-of-the-art patient monitoring solution, supported by a Patient Monitoring Informatics Services Agreement (PMISA), a customized software maintenance service contract that provides
 

  • Access to the latest software upgrades
  • Cybersecurity protection
  • Technical and clinical education, training and support
  • A dedicated Philips Customer Success Manager
     

A central part of PMISA is PerformanceBridge Focal Point, a centralized operational management solution that enables IT and BioMeds to monitor solution uptime and track performance.

At the heart of PMISA is a commitment to deliver high-quality care. We support healthcare professionals by helping them focus on patient care, rather than the equipment – allowing more time at the bedside.
 
Watch how UMC Groningen’s clinicians benefit from this partnership and see how a customized patient monitoring solution could help your organization achieve the same success.

“What the collaboration has primarily achieved…we have been able to relieve the healthcare professional…this means more time is freed up for care, allowing more hands to be used at the bedside.”

Fokke Boorsma

Fokke Boorsma

Head of Medical Technology, University Medical Center Groningen

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Footnotes
 

[1] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129.

[2] Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59.

[3] 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. Japan guidelines

[4] Jeremias A et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001.

[5] Patel M., et al. 1-Year outcomes of blinded physiological assessment of residual ischemia after successful PCI. JACC Cardiol Interv. 2022;15(1):52-61.

[6] FDA 510k (#K173860). The iFR modality is intended to be used in conjunction with currently marketed Philips pressure wires. In the coronary anatomy, the iFR modality has a diagnostic cut-point of 0.89 which represents an ischemic threshold and can reliably guide revascularization decisions during diagnostic catheterization procedure.

[7] Gotberg M. et al. iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI. Late-breaking clinical Trial presentation at TCT on November 4, 2021.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.